INTERNATIONAL GEMOLOGICAL INSTITUTE IPO
Vraj Iron and Steel IPO subscribed nearly 40 times so far on last day. Check GMP and other details
Analysts advised investors to subscribe to the Vraj Iron and Steel IPO as the company's well-established and strategically located manufacturing facilities, coupled with a focus on value-added products and ongoing expansion plans, position it for future growth. The company's shares are trading with a premium of Rs 90 in the unlisted market,
Multibagger Debut! Medicamen Organics stock debuts with 305% premium on NSE SME platform
Medicamen Organics, a pharmaceutical company, saw a successful listing on the NSE SME platform with a substantial premium. The company focuses on international markets, diverse pharmaceutical dosage forms, and global expansion strategies, reflecting its growth potential and market adaptability.
Medicamen Organics IPO allotment expected soon. Check status, GMP, listing date and other details
Medicamen Organics' IPO success signals potential market growth amidst global pharmaceutical advancements, with revenues and profits reflecting promising industry trends.
Vraj Iron and Steel IPO opens. Should you subscribe to this issue?
Considering the Vraj Iron and Steel IPO, investors can explore the opportunity to invest in a company with manufacturing plants in Chhattisgarh, focusing on Sponge Iron production and various steel products. The IPO presents a chance to be part of a well-established firm with growth prospects and strategic manufacturing facilities.
Medicamen Organics IPO booked 916 times at close; GMP at 147% over issue price
Medicamen Organics IPO, with 315 times subscription, plans to raise Rs 10.5 crore for expansion. The company aims to utilize net proceeds for international market registration and production capacity enhancement, targeting a share premium in the unlisted market.
NBFC Avanse Financial files draft prospectus for Rs 3,500 crore-IPO
The Rs 3,500 crore Avanse Financial IPO comprises a fresh equity sale of Rs 1,000 crore and an offer for sale (OFS) of up to Rs 2,500 crore by the existing shareholders. Under the OFS, Olive Vine Investment, International Finance Corporation, and Kedaara Capital Growth Fund III will offload shares. Net proceeds for the issue will be utilised for augmenting the capital base to meet the future capital requirements arising out of the growth of business and assets.
- Go To Page 1
Medicamen Organics IPO opens today: Check issue size, price band, GMP and other details
The SME IPO of Medicamen Organics commenced its subscription on Friday and is scheduled to conclude on June 24. The company intends to raise approximately Rs 10.54 crore through this offering. Once successfully subscribed, the shares will be listed on the BSE SME platform.
Vraj Iron and Steel IPO price band fixed at Rs 195-207/share. Issue to open on June 26
Vraj Iron and Steel, which is set to launch its initial public offering (IPO) on June 26, Wednesday, has disclosed a price band of Rs 195 to Rs 207 per equity share. The IPO includes a fresh issue worth Rs 171 crore.
War, money, oil and the shaping of Aramco's giant share sale
A large chunk of this month's $11.2 billion share sale was allocated to foreign investors, leading one person involved in the process to describe it as the deal the IPO was supposed to be. Its success could create a template for future Aramco sell-downs, which now seem likely as the Crown Prince - who's known as MBS - seeks cash to help fund his multitrillion-dollar Vision 2030 economic transformation project.
Kronox Lab Sciences shares list at 21% premium over issue price
Kronox Lab Sciences boasts a strong position in the specialty fine chemicals sector. Their diverse product portfolio caters to various industries, creating long-term growth potential. High entry and exit barriers due to stringent manufacturing processes offer them a competitive edge.
Int’l investors grabbed bulk of share offering: Saudi Aramco
Saudi Aramco's latest offering raised $11.2 billion with international investors acquiring the majority of shares. The Gulf kingdom aims to boost finances for large-scale projects in preparation for a post-oil future.
Kronox Labs IPO GMP: Will there be a healthy listing at the bourses tomorrow?
Before its debut on the exchanges scheduled for Monday, Kronox Labs' shares are enjoying a premium of Rs 40 in the unlisted market.
Over half of Aramco share sale allocated to foreign investors: Sources
Saudi Arabia placed over half of an $11.2 billion share sale in Aramco with foreign investors, two people with knowledge of the matter told Reuters on Saturday. Saudi Arabia has been seeking to lure international investment to pour tens of billions of dollars into projects to diversify away from its reliance on oil. Yet foreign investment has repeatedly missed targets.
Go Digit’s D-Street debut; Honasa Consumer Q4 financials
Shares of Go Digit General Insurance started trading on the stock market Thursday. More on this in today’s ETtech Top 5.
Go Digit makes stock market debut, gains 12% on issue price
Ahead of the issue opening, the firm raised about Rs 1,176 crore in the anchor round, where Fidelity Investments, Goldman Sachs, ADIA, and Custody Bank of Japan were among the investors.
Go Digit General Insurance IPO subscribed 9.6 times
The Bengaluru based insurtech startup saw the retail portion subscribed 4.3 times, non institutional investors subscribed 7.2 times while qualified institutional buyers subscribed to the IPO 12.5 times. The Fairfax backed startup is looking to go public at a valuation of $3 to $3.2 billion
Go Digit retail portion subscribed 1.4 times
The portion for non-institutional investors was subscribed 0.3 times. Overall, on day 1, the insurtech company's issue was subscribed 0.36 times. Fairfax-backed Go Digit General Insurance, which runs Digit Insurance, had already raised ₹1,176.5 crore from anchor investors a day ahead of its IPO.
Go Digit General Insurance raises Rs 1,176 crore in pre-IPO funding
Fidelity, Goldman Sachs, ADIA, Steadview Capital, SBI MF, ICICI Prudential MF and Axis MF are among the anchor investors that participated. Digit Insurance has set a price band of Rs 258 to Rs 272 per share for its initial public offering, which opened on Wednesday, seeking a valuation of $3-3.2 billion.
Blackstone eyes $300 million IPO of Indian diamond certification firm: Report
Blackstone acquired IGI for $570 million in May 2023 from Chinese conglomerate Fosun and the business's founding Lorie family. IGI has most of its business in India and describes itself as the world's largest independent lab for testing and grading diamonds and other gemstones and jewelry.
GPT Healthcare shares list at 16% premium over IPO price
GPT Healthcare Share Price: GPT Healthcare's IPO debuted with a 16.2% premium. It raised Rs 525 crore for prepayment/repayment of borrowings. The company operates four multispecialty hospitals. Revenue grew at 53.87% CAGR. Three-month total income was Rs 97.63 crore, net profit was Rs 9.98 crore.
GPT Healthcare to debut tomorrow. Here's what GMP indicates ahead of listing
The shares of GPT Healthcare will debut on the exchanges on Thursday. Ahead of the listing, the company's shares are trading with a premium of Rs 17 in the unlisted market.
GPT Healthcare IPO allotment: Check status, listing date, GMP and other details
GPT Healthcare IPO received 8.5 times subscription. Share allotment to be finalized. Check status on BSE or registrar website. Shares trading with Rs 10 premium. Proceeds used for repayment. Competing with listed peers. JM Financial is the sole book running lead manager.
GPT Healthcare IPO fully subscribed on last day. Check GMP and other details
In the unlisted market, the company's shares are trading with a premium of Rs 10, marginally up from the previous week.
GPT Healthcare IPO: Check subscription on Day 2, GMP and other details
The proceeds from the fresh issue will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company besides general corporate purposes.
GPT Healthcare IPO: Check subscription on Day 1, GMP and other details
GPT Healthcare IPO is priced at Rs 177-186 per share for its Rs 525-crore IPO. Investors can make bids for 80 shares in one lot and its multiples thereafter.
GPT Healthcare IPO opens for subscription. Should you apply?
GPT Healthcare IPO: GPT Healthcare's IPO, valued at Rs 525 crore, opened for subscription. The company raised Rs 157 crore from anchor investors. Analysts advise subscribing for fair valuations, comprehensive services, and quality medical practices. The price band is Rs 177-186 per share.
GPT Healthcare IPO to open on Thursday. What GMP signals ahead of subscription?
GPT Healthcare has fixed a price band of Rs 177-186 per share for its Rs 525-crore IPO. The issue closes on February 26. Investors can make bids for 80 shares in one lot and multiples thereafter. The proceeds will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and for general corporate purposes.
GPT Healthcare sets price band of Rs 177-186 for its Rs 525-cr IPO
The IPO is a combination of a fresh issue of equity shares aggregating to Rs 40 crore and an Offer For Sale (OFS) of up to 2.6 crore equity shares by private equity firm BanyanTree Growth Capital II.
Kolkata-based GPT Healthcare announces IPO dates. Check details
The IPO, with a face value of Rs 10, consists of a fresh issue of equity shares, aggregating to Rs 40 crore, and an offer for sale (OFS) of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.
Load More
